Mary Ashcavai

985 citations
23 papers · 760 indexed · h-index 16
Topics
Hepatitis B Virus Studies (16 papers)Liver Disease Diagnosis and Treatment (12 papers)Hepatitis C virus research (7 papers)

In The Last Decade

Mary Ashcavai

22 papers receiving 665 citations

Peers

Mary Ashcavai
Comparison fields: 5 of 69
  • Epidemiology 550
  • Hepatology 475
  • Oncology 106
  • Surgery 86
  • Infectious Diseases 83
Replace Thung Sn with:
Thung Sn United States
Jerrold J. Lander United States
Sk. Md. Fazle Akbar Japan
Thomas London United States
John Hodkinson South Africa
O Inoue Japan
H. Kumada Japan
Hervé Zylberberg France
P Piantino Italy
M Hadchouel France
Mary Ashcavai relative to Thung Sn United States Thung Sn's profile →
Citations per field
00.5×
Thung Sn · 1×
Citations per year

Countries citing papers authored by Mary Ashcavai

Since Specialization
Citations

This map shows the geographic impact of Mary Ashcavai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ashcavai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ashcavai more than expected).

Fields of papers citing papers by Mary Ashcavai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ashcavai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ashcavai. The network helps show where Mary Ashcavai may publish in the future.

Co-authorship network of co-authors of Mary Ashcavai

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ashcavai. A scholar is included among the top collaborators of Mary Ashcavai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ashcavai. Mary Ashcavai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Alpha-fetoprotein and its concanavalin A affinity in acute exacerbation of chronic hepatitis B.
2
2 10
3
Evaluation of anti-HBc IgM estimation by radioimmunoassay for anti-HBc on column separated IgM.
4
4 18
5 18
6 71
7 26
8 30
9 18
10 73
11 1
12 23
13 34
14 81
15
Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens.
94
16
Liver replacement for alpha1-antitrypsin deficiency.
39
17 1
18 20
19 3
20 10

About Mary Ashcavai

Mary Ashcavai is a scholar working on Hepatology, Epidemiology and Infectious Diseases, having authored 23 papers that have together received 760 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (16 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis C virus research (7 papers). The work is most often cited by research in Hepatology (475 citations), Epidemiology (550 citations) and Infectious Diseases (83 citations). Mary Ashcavai has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Robert L. Peters, Masao Omata, Choong-Tsek Liew, Allan G. Redeker, John C. Hoefs, Henry W. Kao, Ian G. Renner, Sugantha Govindarajan, James W. Mosley and Virginia M. Edwards. Their work appears in journals such as The Lancet, Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026